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Dear Members of the New York Medical College (NYMC) Community,
I am happy to share with you the July issue of the School of Medicine
(SOM) research newsletter highlighting important research advances
being conducted by faculty and students in a wide variety of areas,
including diabetes, food allergies, gum disease and kidney donation, as
well as medical education research related to students with disabilities
and anti-bias training.
We are pleased to be able to support this research through programs
such as the Touro University Bridge and Seed Grant Funding Program,
which is highlighted in this newsletter, and I applaud our faculty for the
numerous grants they receive to support their research.
I am also especially pleased to see a record number of medical
students engaged in summer research projects. This may be credited in large part to the dedication of
Mary Petzke, Ph.D., assistant dean for medical student research, and the many faculty mentors who
provide support and encouragement to our students.
As we prepare to welcome the Class of 2026, I hope you will have the opportunity this summer to take
some time away to relax with family and friends. I look forward to sharing more exciting SOM research
news soon.
Sincerely,

Jerry L. Nadler, M.D., MACP, FAHA, FACE
Dean of the School of Medicine
Professor of Medicine and of Pharmacology

Follow the SOM on Facebook

Follow the SOM on Instagram

NYMC Researchers Find Probiotics Can be Used to Treat Severe Gum Disease
NYMC researchers have found that serious gum disease
can be counteracted through the administration of
probiotics. The study, published in the Journal of Clinical
Periodontology, was conducted by a team of members of
the faculty at NYMC, the University of Strasbourg in France
and the French National Institute of Health and Medical

Research (INSERM), and found that oral administration of
live, pasteurized Akkermansia muciniphila (A. muciniphila) ,
a mucus-degrading bacterium with inflammatory properties
commonly found in the human gut, significantly decreased
Porphyromonas gingivalis (P. gingivalis)-induced damage
to the gums.
The NYMC-based research was led by Salomon Amar,
D.D.S., Ph.D., vice president for research and professor of
pharmacology and of pathology, microbiology and
immunology, NYMC, senior vice president for research
affairs, Touro University (TU), and professor of dental
medicine, Touro College of Dental Medicine at NYMC,
along with Hannah Mulhall, Ph.D. ’21, graduate research
associate in the Department of Pathology, Microbiology
and Immunology, and Jeanne M. DiChiara, Ph.D., research
fellow in the Department of Pharmacology. Read the full
story about research on the use of probiotics to treat severe gum disease.

Study Finds USMLE’s Denial of Accommodations Requests by Students with
Disabilities Negatively Impacts Medical Schools
A new study has shown more than half of medical students with disabilities
from a sample of U.S. medical programs were denied accommodations by
the organization that administers the United States Medical Licensing
Exam (USMLE) Step 1. The international team of researchers, which
included lead author of the study Kristina H. Petersen, Ph.D., assistant
dean of academic support programs and assistant professor of
biochemistry and molecular biology, found these rejections detrimentally
impacted both students and the medical schools they attend. The
paper, “Impact of USMLE step-1 accommodation denial on US medical
schools: a national survey,” was recently published in PLOS One.
The USMLE Step 1 exam, typically administered after a student completes
two years of medical school, assesses whether that student can apply key
concepts of basic science underpinning the practice of medicine, with
emphasis on principles of health, disease and therapy. It includes a oneday examination, divided into seven, 60-minute blocks and administered in one eight-hour testing
session. Read the full story about the study on the impact of USMLE’s denial of accommodations .

Focus on Beta Cells Instead of Immune System Could be Key to Preventing
Type 1 Diabetes
Research into the causes of type 1 diabetes often focuses
on the autoimmune response, where the immune system
destroys pancreatic islet beta cells that produce insulin. A
new study by a national team of researchers, which
included Jerry L. Nadler, M.D., MACP, FAHA, FACE,
left, dean of the SOM and professor of medicine and
pharmacology, and Raghavendra Mirmira, M.D., Ph.D.,
professor of medicine and director of the Diabetes
Translational Research Center at the University of Chicago
(UChicago), instead examined the role of the beta cells
themselves in triggering autoimmunity. The research also
raises the possibility that new medications could block the
immune system from destroying beta cells and prevent
type 1 diabetes from developing in at-risk or early onset
patients.

The study, published in Cell Reports, describes how the
researchers used genetic tools to knock out or delete a
gene called Alox15 in mice that are genetically
predisposed to developing type 1 diabetes. This gene
produces an enzyme called 12/15-Lipoxygenase, which is
known to be involved in processes that produce
inflammation in beta cells. Deleting Alox15 in these mice
preserved their amount of beta cells, reduced the number
of immune T-cells infiltrating the islet environment and
prevented type 1 diabetes from developing in both males
and females. These mice also showed increased
expression of the gene encoding a protein called PD-L1
that suppresses autoimmunity.
“The immune system doesn't just decide one day that it’s
going to attack your beta cells. Our thinking was that the
beta cell itself has somehow fundamentally altered itself to
invite that immunity,” said Dr. Mirmira. “When we got rid of this gene, the beta cells no longer signaled to
the immune system and the immune onslaught was completely suppressed, even though we didn't
touch the immune system,” he said. “That tells us that there is a complex dialogue between beta cells
and immune cells, and if you intervene in that dialogue, you can prevent diabetes.”
Dr. Nadler is credited with the discovery in his own lab of the role of the 12/15-Lipoxygenase enzyme.
“This is an important finding in the field of type 1 diabetes research and represents a clear example of
the benefits of team science and collaboration,” said Dr. Nadler. “It continues to be a great joy to have
the long-term opportunity to collaborate with Dr. Mirmira and his team.” Read the full story on the study
on preventing type 1 diabetes.

Plant Compound Shows Promise for Alleviating Food Allergies
With nearly 10 percent of the world population affected by
food allergies — which are sometimes life-threatening —
new treatments are critically needed. Researchers in the
lab of Xiu-Min Li, M.D, M.S., (right in photo) professor of
pathology, microbiology and immunology and
otolaryngology, have found that the plant compound
formononetin has great potential to treat food allergies.
Found in plants and herbs such as red clover and green
beans, formononetin is a phytoestrogen, which can bind to
the body’s estrogen receptors, and has been shown to
have anticancer properties.
“Our findings show that formononetin is a particularly good
therapeutic candidate for treating food allergies,” said
Ibrahim Musa, M.S., (left in photo) a doctoral candidate in
Dr. Li’s lab. “Our research also revealed new mechanisms and targets that can be utilized to design
future drugs for treating food allergies and other allergic disorders or to prevent severe anaphylaxis seen
in allergic diseases.” Mr. Musa presented the research at the American Society for Biochemistry and
Molecular Biology annual meeting in April and the manuscript was recently accepted for publication in
the FASEB Journal. Read the full story on research on formononetin .

Cara Grimes, M.D., Recognized for Most Impactful Research Article of
2020 by International Urogynecological Association

Cara Grimes, M.D., (third from left) associate professor of obstetrics and gynecology and of urology,
was recognized for the most impactful research article of 2020 by the International Urogynecological
Association (IUGA) on June 17, 2022, during the IUGA’s annual business meeting in Austin, TX. Dr.
Grimes and her fellow researchers from across the country received the Oscar Contreras Ortiz
Award for their article “A Guide for Urogynecologic Patient Care Utilizing Telemedicine During the
COVID-19 Pandemic: Review of Existing Evidence,” which was published in the International
Urogynecology Journal in June 2020. The Oscar Contreras Ortiz Award was first bestowed in 2018 to
honor the memory and legacy of Oscar Contreras Ortiz, co-founder of the International Urogynecology
Journal and IUGA President from 1996-1998.
“This award is one that I will treasure greatly,” said Dr. Grimes. “This research paper grew out of
collaboration during the early days of the COVID-19 pandemic. During this time when outpatient
offices/clinics were closed, I, as a physician, felt ungrounded and unguided with no clear direction on
how best to treat my patients. I turned to a group of my colleagues around the country and we came
together to do a rapid systematic review and meta-analysis of existing literature in an effort to guide us. It
is gratifying to have our work recognized and know that it has been read and cited by many of my
colleagues around the world, and hopefully that it supported them to provide quality care to patients
during the pandemic.”

NYMC Researchers Validate Effectiveness of Tool to Determine Patient
Recovery After Kidney Donation
With kidney transplantation the best treatment option for patients with
end-stage renal disease, living-donor kidney transplantation has
increasingly been looked to as a solution for donor shortage. Yet donor
nephrectomy does not come without risks. In a new study, published in
Transplant Proceedings, a team of NYMC researchers validated the
effectiveness of a tool to calculate how well patients who donated a
kidney will recover.
“Donating a kidney is an incredibly honorable act, and it is very important
that we do our best as medical professionals to make sure that the
donors as well as the recipients of the kidneys, have positive outcomes,”
said Holly Grace, SOM Class of 2023, who was second author on the
study.
For the study, the NYMC researchers examined characteristics of the
donors, including age, race, BMI and kidney function before transplant and then applied the
compensation prediction score (CPS) formula to calculate how well the donor's remaining kidney would
function after the transplant. “By validating this calculation, we showed that the tool can also be used
among the United States population to predict remnant kidney function after donation,” said Ms. Grace.

The use of CPS as a validation tool was first reported in a 2019 study conducted in Japan that was lead
authored by Kenji Okumura, M.D., now a research fellow at Westchester Medical Center, NYMC’s
primary clinical affiliate. In addition to Dr. Okumura and Ms. Grace, other authors on the study included:
Hiroshi Sogawa, M.D., associate professor of surgery; Gregory Veilette, M.D., assistant professor of
surgery; Devon John, M.D., assistant professor of surgery; Nandita Singh, M.D., clinical assistant
professor of medicine; Daniel Glicklich, M.D., professor of medicine; Seigo Nishida, M.D., Ph.D., clinical
professor of surgery; and Thomas Diflo, M.D., professor of surgery.

SOM Students Develop Implicit Bias Training Program with Positive Results
As leaders in health care teams, physicians can play an integral role in identifying, addressing and
teaching others how to mitigate the impact of implicit bias on patient interactions and health outcomes.
However, limited research has focused on curricular design to recognize and address implicit bias early
in medical training, especially for medical students in pre-clinical training. To address this disparity, a
group of SOM students collaborated to design and implement an implicit bias training program for firstand second- year medical students. The program has not only received very positive feedback from
SOM students but has also been presented at several conferences, including the University of Michigan
Annual Diversity in Medicine Conference, the American Medical Student Association National
Conference, the Annual Medical Society of the State of New York Conference and the University of
North Carolina Annual Minority Health Conference.
“As medical students ourselves, we wanted to create a program that addressed this educational gap in a
way that would resonate with our fellow students. For this reason, we developed a virtual curriculum that
included not only didactic learning but also real-life scenarios of implicit bias, including racism,
sexism and ableism. We hoped that tailoring the training to scenarios future students might find
themselves in would make the concepts taught more memorable and the strategies we discussed more
applicable. Based on student testimonials provided in the post-session survey, it seems we succeeded,”
said Forouhideh Peyvandi, SOM Class of 2023, who worked with fellow members of the Class of
2023 Ebtisam Zeynu, Madison Kasoff, Joshua Buckley and Mariah Fontanez-Lutsky under the
mentorship of Dr. Mill Etienne, M.D.’02, M.P.H., vice chancellor for diversity and inclusion and associate
dean for student affairs, to develop the program.
To date, more than 400 students have participated in the program, and student feedback has
demonstrated an overwhelmingly positive response with students expressing a much higher comfort
level in discussing implicit bias and a strong interest in continued curricular experiences. The training
has been expanded to include physical therapy students at NYMC, and possibly in the future will include
longitudinal training that extends to third- and fourth-year SOM students.

Touro University Bridge and Seed Funding Grant Program Recipients
Announced
Several NYMC faculty are the recipients of the Spring 2022 Bridge and Seed Funding Grants from TU.
Bridge Funding Grant Program:
Sachin A. Gupte, M.D., Ph.D., professor of pharmacology
“Regulation of Vascular Smooth Muscle Tissue Cell Phenotype by a Novel Isoform of Glucose-6
Phosphate Dehydrogenase”
Michal Laniado Schwartzman, Ph.D., professor and chair of Department of Pharmacology
“GPR75 in Obesity-driven Cardiovascular and Metabolic Complications”
Seed Funding Grant Program:
Victor Garcia, Ph.D., assistant professor of pharmacology
Tetyana Cheairs, M.D., M.P.H., assistant professor of pathology, microbiology and immunology
Michael Shakarjian, Ph.D., assistant professor of public health
“Characterization of a 20-HET Receptor (GPR75) Blocker for the Prevention of Obesity and Liver
Disease (NALFD)”
Marcello Rota, Ph.D., research assistant professor of physiology

Sudhir Jain, Ph.D., associate professor of pathology, microbiology and immunology
Hong Duck Kim, Ph.D., associate professor of public health
“Events Triggering the Manifestation of Cardiometabolic Syndrome”
Patric Stanton, Ph.D., professor of cell biology and anatomy and of neurology
John A. Sullivan, M.D., Ph.D., assistant professor of Physician’s Assistant Program
“The Role of the Pro-Diabetes Inflammatory Transcription Factor STAT4 in Alzheimer’s Disease”
According to Salomon Amar, D.D.S., Ph.D., vice president for research at NYMC and senior vice
president for research affairs at TU, “The Bridge and Seed Funding Grant programs are one of several
initiatives, both system-centric and campus-centric, by which we seek to recognize both great promise of
our junior faculty and ongoing excellence of senior faculty, all in support of research as a fundamental
component of Touro’s mission. On behalf of our entire research community, please join me in
congratulating all of our faculty awardees and wishing them every success.”

Grants Corner
Katherine Amodeo, M.D., assistant professor of neurology, received a $150,000 grant from
Aptinyx for “A study to evaluate NYX-458 in Subjects with Mild Cognitive Impairment or Mild
Dementia Associated with Parkinson's disease or Prodromal or Manifest Lewy Body Dementia.”
Matthew Bronstein, M.D., clinical assistant professor of surgery, received a $163,995 grant
from Duke University/RTI/Labcorp for "COVID-19 Post-hospital Thrombosis Prevention Study: A
multicenter, adaptive, prospective, randomized, placebo-controlled platform trial evaluating the
efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital
discharge.”
Doris Bucher, Ph.D., associate professor of pathology, microbiology and immunology and of
pediatrics, received a $956,604 grant from the International Federation of Pharmaceutical
Manufacturers and Associations for "High Yield Reassortant Viruses for Influenza Vaccine."
Mitchell Cairo, M.D., professor of pediatrics, cell biology and anatomy, medicine and of
pathology, microbiology and immunology, received a $1,097,468 grant from Merck/PRA for “A
Phase 2 Open-label Clinical Study to Evaluate the Efficacy and Safety of Zilovertamab Vedotin
(MK-2140) in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma” and a
$125,554 grant from Merck for “A Phase 2/3 Multicenter, Open-label, Randomized, ActiveControl Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in
Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.”
Daniel Cho, M.D., professor of medicine, received a $50,000 grant from Pyramid for “A Phase
1/2 Study of PBI-200 in Subjects with NTRK-Fusion-Positive Advanced or Metastatic Solid
Tumors.”
Thomas Diflo, M.D., professor of surgery, received a $27,425 grant from the NIH for “APOL1
Long-term Kidney Transplantation Outcomes Network (APOLLO).”
Chirag Gandhi, M.D., professor and chair of Department of Neurosurgery, professor of
neurology and of radiology, received a $130,524 grant from Stryker Neurovascular for
"SELECT2: A Randomized Controlled Trial to Optimize Patient’s Selection for Endovascular
Treatment in Acute Ischemic Stroke.”
Simon Hanft, M.D., associate professor of neurosurgery, received a $112,675 grant from GT
Medical Technologies for “A Multicenter Observational Study of GammaTile™ Surgically
Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms.”
Supriya Jain, M.D., clinical associate professor of pediatrics and assistant professor of
radiology, received a $207,527 grant from Acumen for "COVID-19 Vaccination-Associated
Myocarditis in Adolescents: Follow Up Study."
Jerry Nadler, M.D., dean of the SOM and professor of pharmacology and of medicine, received
a $47,801 grant from Veralox Therapeutics for "Development of New Inhibitors to Treat

Inflammatory Damage of COVID-19."
John Phillips, M.D., professor of urology, received a $66,500 grant from CoImmune for "A
Phase 2b Randomized Trial of Autologous Dendritic Cell Immunotherapy (CMN-001) Plus
Standard Treatment of Advanced Renal Cell Carcinoma.”
Justin Santarelli, M.D., assistant professor of neurosurgery, received a $680,766 grant from
Micro Therapeutics/Medtronic for "Embolization of the Middle Meningeal Artery with ONYX™
Liquid Embolic System In the Treatment of Subacute and Chronic Subdural Hematoma
(EMBOLISE).”
Patric Stanton, Ph.D., professor of cell biology and anatomy and of neurology, received a
$156,000 grant from Gate Neuroscience for "NMDA Receptor Modulators as Neurotherapeutics.”
Francis Winski, Jr., M.D., clinical assistant professor of surgery and of otolaryngology, received
a $34,289 grant from the American Burn Association for “The Acute Burn Resuscitation
Multicenter Prospective Trial – 2.”
Steven Wolf, M.D., clinical professor of pediatrics, received a $97,618 grant from Neurelis for
“An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® with Open-Label Safety
Period in Pediatric Subjects with Epilepsy (DIAZ.001.08), a $94,568 grant from Neuropace for
“Responsive Stimulation for Adolescents with Epilepsy (RESPONSE) Study” and a $67,581
grant from PRA Health Sciences for Open-Label, Single-Arm, Multicenter Study to Evaluate
Long-Term Safety and Tolerability of Brivaracetam Used as Adjunctive Treatment in Pediatric
Study Participants with Epilepsy.”
Gary Wormser, M.D., professor of medicine, pharmacology and of pathology, microbiology and
immunology, received a $100,000 grant from New York State for "New York Medical College –
Lyme Disease Diagnostic Center."

NYMC Students and Faculty Shine at Touro University Research Day
As part of Touro University’s (TU) 50th Anniversary
series of celebratory events, the first Research Day for
the entire TU community took place on May 3. The
event recognized the best faculty research publications
in 2019 and the best student posters presented at
Research Day 2022. Ph.D. candidates in microbiology
and immunology Michelle Carnazza (left in photo)
and Tara Jarboe (right in photo) and M.D./Ph.D.
candidate Sina Dadafarin won for best student
posters, while faculty members Julio Panza, M.D.,
professor of medicine and chief of the Division of
Cardiology, and Sangmi Chung, Ph.D., associate
professor of cell biology and anatomy, were recognized for their publications.
Posters were selected for presentation by a multi-step process to highlight the best research projects
throughout TU. After rigorous local judging, a final group of posters was chosen for presentation in four
categories with first and second place prizes. Students in the Department of Pathology, Microbiology
and Immunology swept the basic sciences and natural sciences category. Read the article on the
winning projects.

Clinical Affiliates and Academic Departments Host Research Days
In recent months, both NYMC clinical affiliates and
academic departments have hosted research
events, highlighting the important projects
underway by faculty, students and residents.

The Department of Surgery hosted the 19th
Annual Louis R.M. DelGuercio Distinguished
Visiting Professorship and Research Day on
May 6, with keynote speaker Rifat Latifi, M.D.,
former chair of the Department of Surgery and now
Minister of Health for the Republic of Kosova.
During his address, Dr. Latifi shared his perspective
on mitigating health disparity and transforming
healthcare in Kosova through Centers of
Excellence.
Sponsored annually since 2002, the Louis R.M.
DelGuercio Research Day is named for the late
Louis R.M. Del Guercio, M.D., professor emeritus of surgery, who served as chair of the Department for
24 years before retiring in 2000. The event provides students, residents and fellows, with both an
opportunity to showcase their research and an occasion to network, learn from one another and
potentially combine efforts to promote the advancement of surgical research. Read the full list of award
winners.
On May 20, the Department of Medicine highlighted
recent research by residents and fellows at an event at
Maria Fareri Children’s Hospital. More than 20
residents and fellows were chosen to present their
projects at the event with several winners chosen,
which included: Best Resident Case Report - Liana
Michaud, D.O., for "Kratom Toxicity: A Rare Case of
Severe Pancreatitis, Rhabdomyolysis,
Cardiomyopathy, and ATN" (Liana Michaud, D.O.,
Abhinaya Sridhar, M.B.B.S., Matthew Seplowe, D.O.,
Ester Sherman, M.D., Sally Ziatabar, D.O., Lisa Paul,
M.D., assistant professor of medicine); Best Resident
Research/QI Project - Areen Pitaktong, M.D., for "Does COVID-19 Party on the Weekend?" (Areen
Pitaktong, M.D., Neil Schluger, M.D., professor and chair of Department of Medicine); Best Fellow Case
Report - Maria Velasquez, M.D., for "Use of PCR and MLST analysis to establish Treponema pallidum
as the cause of a painful oral lesion" (Maria Velasquez, M.D., Gary P. Wormser, M.D., professor of
medicine, pharmacology and of pathology, microbiology and immunology, Marina Keller, M.D., assistant
professor of medicine); and Best Fellow Research/QI Project - Aaqib Malik, M.D., M.P.H., clinical
assistant professor of medicine, for "30-day readmission rate of same-day discharge protocol following
Transcatheter aortic valve implantation: A propensity score-matched analysis from National
Readmission Database" (Aaqib H Malik, M.D., M.P.H., Akshay Goel, M.D., Dhrubajyoti Bandyopadhyay,
M.D., Sandipan Chakraborty, M.D., Rahul Gupta, M.D., J. Dawn Abbott, M.D., Hasan Ahmad, M.D.,
clinical associate professor of medicine).
The Department of Neurology
held their inaugural Neuroscience
Research Symposium on May 25,
which celebrated ongoing
achievements and cutting-edge
neuroscience research by NYMC
faculty, resident and students. At
the symposium, Walter
Koroshetz, M.D., director of the
National Institute on Neurological
Disorders and Stroke, delivered
the keynote address.
Award winners at the symposium included: Best Neurosurgical Abstract Award – Jared Cooper, M.D.
’16, instructor of neurosurgery, for “Endovascular thrombectomy for treatment of pediatric stroke: safety
and outcome data from a national inpatient sample”; and Steve Shapiro, M.D., for “Characteristics and
outcomes of acute stroke patients with cancer in the modern thrombectomy era”; Neurosurgical
Research Resident Award -- Jose Dominguez, M.D. for “Cerebral Venous Thrombosis in COVID-19: A
New York Metropolitan Cohort Study”; Clinical Neurosciences Research Fellow Award -- Eric Feldstein,
M.D. ’21 for “Ruptured Arteriovenous Malformation Mortality: Incidence, Risk Factors, and Inpatient

Outcome Score”; Best Medical Student Neurological Abstract Award -- Maya Pandit, M.P.H., SOM Class
of 2023, for “Racial Disparities Among Migraine Clinical Trials between 1995-2021”; and Aiden Lui, SOM
Class of 2024, for “Outcomes of Heparin Induced Thrombocytopenia Type II in Aneurysmal
Subarachnoid Hemorrhage Patients: A National Inpatient Sample Analysis: A Cross-Sectional Analysis”;
Young Investigator Award -- Alis J. Dicpinigaitis, SOM Class of 2023, for “Increased Incidence of
Ruptured Cerebral Arteriovenous Malformations and Mortality in the United States: Unintended
Consequences of the ARUBA Trial?”
The NYMC-sponsored Internal Medicine Residency Program at
St. Michael’s Medical Center hosted its first research symposium
on May 19, where residents and fellows were invited to participate in
poster and oral presentations on a wide array of topics. Poster
presentation winners included: Modupeoluwa Temitope Owolabi,
M.D., pictured below left, (First Place) for “A Rare Case of
Pyrethroid Poisoning Presenting as Auditory Hallucination” and
Raed Atiyat, M.D., pictured at right, (Second Place) for “A Rare
Case of Propofol Infusion Syndrome in a Male with Diabetic
Ketoacidosis.” Chosen for best oral presentation were Iyad Farouji,
M.D., pictured below right, (First Place) for “Cerebral Air Embolism
after Gastrointestinal Procedure: A Case Report and Literature
Review” and Sindhusha Veeraballi, M.D. (Second Place) for “The Role of Bisphosphonates in Solid
Tumors.” Winners are pictured with program director Ted DeCosta, M.D.

Faculty and Student Publications and Accolades
Maha Alqahtani, GSBMS student; and Chandra Bakshi, D.V.M., Ph.D., associate professor of
pathology, microbiology and immunology, published “ThioredoxinA1 Controls the Oxidative
Stress Response of Francisella tularensis Live Vaccine Strain (LVS)” in the Journal of
Bacteriology.
Chun Peng Chao, M.D., assistant professor of pediatrics; Erin Rescoe, M.D., clinical assistant
professor of pediatrics; and Sonia Solomon, D.O., assistant professor of pediatrics; published
“The use of ECMO in pediatric granulomatosis with polyangiitis” in Pediatric Rheumatology.
Joshua Goldberg, M.D., assistant professor of surgery; Suguru Ohira, M.D., Ph.D., clinical
assistant professor of surgery; David Spielvogel, M.D., professor of surgery; and Masashi Kai,
M.D., clinical associate professor of surgery, published “Successful Heart Transplantation
Recovered From a Brain-Dead Donor on Veno-Arterial Extracorporeal Membrane Oxygenation
Support” in Asaio Journal.
Jessica Hochberg, M.D., associate professor of pediatrics; Liana Klejmont, Pharm.D.,
instructor of medicine; Chitti Moorthy, M.D., professor of clinical radiation medicine; Humayun
Islam, M.D., Ph.D., clinical professor and chair of Department of Pathology, Microbiology and
Immunology; Perry Gerard, M.D., professor of radiology and of medicine; and Mitchell Cairo,
M.D., professor of pediatrics, medicine, cell biology and anatomy and of pathology, microbiology
and immunology; published “Risk-adapted chemoimmunotherapy using brentuximab vedotin and

rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma:
a phase II, nonrandomized controlled trial” in the Journal for Immunotherapy of Cancer.
Sudhir Jain, Ph.D., associate professor of pathology, microbiology and immunology; Jason
Jacobson, M.D., associate professor of medicine; and Marcello Rota, Ph.D., research assistant
professor of physiology; published “Heart Rate Variability Reveals Altered Autonomic Regulation
in Response to Myocardial Infarction in Experimental Animals” in Frontiers in Cardiovascular
Medicine.
Humayun Islam, M.D., Ph.D., clinical professor and chair of Department of Pathology,
Microbiology and Immunology; Rugved Pattarkine, M.D., instructor of pathology, microbiology
and immunology; Angelica Mares-Miceli, M.D., assistant professor of pathology, microbiology
and immunology; and Patrick Lento, M.D., professor of pathology, microbiology and
immunology and of medicine; published “Measuring the Efficacy of Pathology Career
Recruitment Strategies in US Medical Students” in the Archives of Pathology & Laboratory
Medicine.
Edward Lebovics, M.D., professor of medicine, published “Part 1: Disease of the Heart and
Liver A Relationship That Cuts Both Ways” in Cardiology in Review.
Danielle Maraia, SOM Class of 2024; Steven Hemmerdinger, M.D., assistant professor of
otolaryngology; Hasit Mehta, M.D., clinical associate professor of radiology, neurology and of
neurosurgery; Sana Ali, M.D., clinical assistant professor of radiology; Javin Schefflein, M.D.,
clinical assistant professor of radiology; and Maynard High, Ph.D., associate professor of
radiology; published “Dual-layer spectral CT virtual-non-contrast images aid in parathyroid
adenoma analysis and radiation dose reduction: confirmation of findings from dual CT” in Clinical
Imaging.
Jerry Nadler, M.D., SOM dean and professor of pharmacology and of medicine, published
“Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for
discovery and translation” in Nature Genetics.
Srihari Naidu, M.D., professor of medicine, published “Outcomes of rotational atherectomy
followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified
coronary lesions: A meta-analysis” in Catheterization and Cardiovascular Interventions.
John Pinto, Ph.D., professor of biochemistry and molecular biology and of medicine; and Arthur
Cooper, Ph.D., D.Sc., published “The metabolic importance of the glutaminase II pathway in
normal and cancerous cells” in Analytical Biochemistry.
Xiao Lei Zhang, M.D., Ph.D., research assistant professor of cell biology and anatomy; and
Patric Stanton, Ph.D., professor of cell biology and anatomy and of neurology; published
“Extracellular application of the N-methyl-D-aspartate receptor allosteric modulator rapastinel
acts remotely to regulate Ca2+ inactivation at an intracellular locus” in NeuroReport.
Allison Zhong, M.D. ’22; Anaz Uddin, SOM Class of 2025; Eric Feldstein, M.D. ’21; Joon
Yong Chung, SOM Class of 2024; Maziyah Ogarro, SOM Class of 2024; Rebecca Friedman,
SOM Class of 2024; Josh Simmons, SOM Class of 2024; Gillian Graifman, SOM Class of
2024; Christeena Kurian, M.D., clinical assistant professor of neurology; Gurmeen Kaur,
M.B.B.S., assistant professor of neurology and of neurosurgery; Stephan Mayer, M.D.,
professor of neurology and of neurosurgery; Chirag Gandhi, M.D., professor and chair of
Department of Neurosurgery; professor of neurology and of radiology; and Fawaz Al-Mufti,
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